Navigation Links
Takeda Launches New Subsidiary in Peru
Date:8/22/2013

ZURICH, August 22, 2013 /PRNewswire/ --

Demonstrates Takeda's long-term commitment to the Latin American market

Takeda Pharmaceuticals International GmbH ("Takeda") today announced further expansion of its presence in Latin America with the launch of a wholly-owned subsidiary in Peru. Takeda Peru S.R.L. (Takeda Peru or "the Company") will be headquartered in Lima and will be responsible for the sales and marketing of Takeda's products in Peru.

Takeda is building a leading position in Latin America. It has a direct presence in Brazil, Mexico, Argentina, Venezuela, Colombia, Ecuador and now Peru, and is looking at opportunities to further expand its footprint in the region. According to IMS Market Prognosis, pharmaceutical sales in those countries totaled US$60 billion in 2012 and are expected to grow at a compound annual rate of 12.5%* between 2013 and 2017. Takeda plans to outgrow the market over the same period.

Peru is a dynamic and growing market, driven by government investment and strong mining industries. It is estimated that the country's GDP totaled US$ 200 billion in 2012 while pharmaceutical sales amounted to US$1.5 billion and are expected to continue to grow by 8% during 2013*.

In line with Takeda's emerging markets strategy, Takeda Peru is building a product portfolio based on the medical needs of the population, focusing on gastroenterology, cardiology, metabolism, oncology and respiratory diseases. The Company will initially focus on Zurcal (pantoprazole), Riopan (Magaldrate + Dimeticone) Faktu (Policresul
'/>"/>

SOURCE Takeda Pharmaceuticals International GmbH
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Data Published in the New England Journal of Medicine for Vedolizumab, an Investigational New Drug from Takeda for Moderately to Severely Active Ulcerative Colitis and Crohns Disease
2. Among New Agents Entering the Unipolar Depression Market Over the Next Decade, Lundbeck/Takeda Pharmaceuticals Brintellix Has Blockbuster Potential
3. Takeda Submits Biologics License Application for a New Investigational Drug Vedolizumab, in Moderately to Severely Active Crohns Disease and Ulcerative Colitis in the United States
4. Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States
5. AGA Research Foundation Announces Endowment Gift from Takeda Pharmaceuticals U.S.A., Inc. to Support Gastroenterology Research
6. Takeda to Acquire Inviragen, Inc.
7. Takeda Responds to Verdict in Diabetes Drug Case
8. Takeda Launches New Subsidiary in Ecuador
9. Takeda lanza nueva subsidiaria en Ecuador
10. Scripps Research Institute and Takeda Pharmaceuticals Announce Expanded Research Collaboration
11. Takeda presenta la richiesta di autorizzazione allimmissione in commercio nellUnione Europea per Vedolizumab nella colite ulcerosa moderata-grave e nella malattia di Crohn
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... Mich. , June 29, 2015  New ... and American Stroke Association give hope for better ... who experience an acute ischemic stroke each year. ... the key products used in the clinical trials ... The new AHA/ASA guidelines strongly recommend endovascular therapy ...
(Date:6/29/2015)...  Nevro Corp. (NYSE: NVRO ), a global ... for the treatment of chronic pain, today announced that ... of Intersect ENT (NASDAQ: XENT ), has been ... 2015. For the last seven years, ... a company dedicated to improving the quality of life ...
(Date:6/29/2015)... ZIONA, Israel , June 29, 2015 ... TASE: BVXV) today announced positive preliminary results from its ... for a universal influenza vaccine. In this trial, M-001 ... 50 to 65, followed by an administration of the ... M-001 was found to be safe and well tolerated ...
Breaking Medicine Technology:New AHA Guidelines For The Early Management And Treatment Of Stroke Will Change The Standard Of Care For Thousands Of Stroke Patients Each Year 2New AHA Guidelines For The Early Management And Treatment Of Stroke Will Change The Standard Of Care For Thousands Of Stroke Patients Each Year 3Nevro Appoints Lisa Earnhardt to its Board of Directors 2BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults 2BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults 3
... YORK , June 24 Reportlinker.com announces that a new market research report ... Global Hernia Repair Devices ... http://www.reportlinker.com/p0209282/Global-Hernia-Repair-Devices-Industry.html , ... This report analyzes the Global market for Hernia Repair Devices in US$ Million by the ...
... June 24 Today the United ... (CDC) issued new and important guidelines on the detection ... of tuberculosis (TB). In these landmark guidelines, CDC advises ... now preferred over the 100+-year-old tuberculin skin test (TST) ...
Cached Medicine Technology:Reportlinker Adds Global Hernia Repair Devices Industry 2Reportlinker Adds Global Hernia Repair Devices Industry 3Reportlinker Adds Global Hernia Repair Devices Industry 4Reportlinker Adds Global Hernia Repair Devices Industry 5Reportlinker Adds Global Hernia Repair Devices Industry 6Reportlinker Adds Global Hernia Repair Devices Industry 7Reportlinker Adds Global Hernia Repair Devices Industry 8Reportlinker Adds Global Hernia Repair Devices Industry 9Reportlinker Adds Global Hernia Repair Devices Industry 10New CDC Guidelines Prefer Use of Blood Tests, Including QuantiFERON®-TB, to Diagnose Tuberculosis Infection in Certain Populations 2New CDC Guidelines Prefer Use of Blood Tests, Including QuantiFERON®-TB, to Diagnose Tuberculosis Infection in Certain Populations 3New CDC Guidelines Prefer Use of Blood Tests, Including QuantiFERON®-TB, to Diagnose Tuberculosis Infection in Certain Populations 4New CDC Guidelines Prefer Use of Blood Tests, Including QuantiFERON®-TB, to Diagnose Tuberculosis Infection in Certain Populations 5
(Date:6/29/2015)... , ... June 29, 2015 , ... With Urgent Care ... a partnership with the American Board of Urgent Care Medicine and the Medical Society ... 1 Credit™ to Urgent Care physicians and health care professionals. , According to Matthew ...
(Date:6/29/2015)... , ... June 29, 2015 , ... OR Manager announced ... revitalized look and feel, as well as a redesigned logo and weekly eLetter. The ... but is now more user-friendly and easier to navigate. , In addition to ...
(Date:6/29/2015)... ... 29, 2015 , ... The Food Safety and Technology Research ... Kong Polytechnic University (PolyU) has developed a new method for rapid authentication of ... a long-term issue in food safety, and becomes particularly important with the emergence ...
(Date:6/29/2015)... ... June 29, 2015 , ... DISC, a ... is a popular focus for corporate training seminars. As many as seventy percent ... training, foster teamwork, and increase productivity. , With the demand for in-house ...
(Date:6/29/2015)... ... June 29, 2015 , ... Wheel:Life, ... Travel Guide for Wheelchair Users as a new e-book on Amazon.com. Wheel:Life publications ... , These accessible travel suggestions were crowdsourced by the Get Out & Enjoy ...
Breaking Medicine News(10 mins):Health News:Exam Master Partners to Provide New Urgent Care Continuing Medical Education Resource 2Health News:Exam Master Partners to Provide New Urgent Care Continuing Medical Education Resource 3Health News:OR Manager Launches New Website 2Health News:PolyU develops a new method for rapid authentication of edible oils and screening of gutter oils 2Health News:As Demand for DISC Trainers Rises, PeopleKeys Offers Support with “THE DISC FACTOR—Train the Trainer” Webinar 2Health News:Wheel:Life Publishes Accessible US Travel Guidebook for Wheelchair Users 2Health News:Wheel:Life Publishes Accessible US Travel Guidebook for Wheelchair Users 3
... malady that many suffer from, it often breeds discomfort and ... to overcome it those struggling with this malady ... in causing bad breath//. In the absence of any clear-cut ... mouth rinses are usually resorted to. ,Statistics ...
... in the gray matter has offered an insight into a ... introduction – SELFISHNESS//. Bewildering all the same, why are some ... others believe in being the epitome of selflessness! ... at the front of the brain, termed as the dorsolateral ...
... caught between the devil and the deep sea, unable to ... of emergency mental// healthcare. The patient, a 17 year old ... form of counseling was attempted. ,The girl suffered ... suicide attempts. According to the mother, her daughter was ...
... According to the Idaho health officials, the kid who died ... E. coli strain in the tainted spinach that has caused ... boy, Kyle Allgood, from Chubbuck, Idaho, who died on Sept. ... bacteria outbreak that has sickened 192 people in the United ...
... first time issued Global Air Quality Guidelines on Thursday so ... million// people each year with most of the deaths occurring ... to enhance air quality in the cities. A statement issued ... 3,00,000 lives could be saved every year by bringing down ...
... Andhra Pradesh carry the HIV virus, which is passed on to ... (APSACS) has come to the aid of such infants, suffering HIV ... society strives to realize infant births sans HIV by the year ... country, the group has lined up the Telugu Network of HIV ...
Cached Medicine News:
Solid lower plate with outside width 15 mm. Open serrated upper plate with inside dimensions 9 x 12 mm. Serrated handle with locking thumb screw and polished finish....
Narrow smooth jaws. Serrated handle with polished finish....
14 mm oval solid lower plate and straight 9 mm serrated upper jaw. Locking thumb screw and serrated handle with polished finish....
Round solid 10 mm wide lower plate. Open upper plate with inside diameter 8 mm. Serrated handle with locking thumb screw and polished finish. Most popular size or model....
Medicine Products: